About Index Trending news
Analyze
Pricing
MATINAS BIOPHARMA

MATINAS BIOPHARMA

Work at MATINAS BIOPHARMA? Add yourself to this profile

MATINAS BIOPHARMA

Matinas (OTCQB: MTNB) is identifying & developing safe/effective antifungal & anti-bacterial therapeutics for treatment of serious & life-threatening infections
Edit Profile
More info

Elsewhere

Companies in the same industry

Cidara Therapeutics Cidara Therapeutics Denali Therapeutics Denali Therapeutics Theranica Theranica Motus Therapeutics Motus Therapeutics Arsia Therapeutics Arsia Therapeutics Nativis Inc. Nativis Inc. Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) Alder Biopharmaceuticals Inc. (Nasdaq: ALDR) AntriaBio AntriaBio Prosensa Prosensa IRX Therapeutics, Inc. IRX Therapeutics, Inc.

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Latest funding
Venture capital (Series A)
$4,400,000
Venture capital
$10,000,000
Employees

Unknown size

Locations
HQ
United States
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when MATINAS BIOPHARMA makes some noise.